House hearing on silicone breast implants
This article was originally published in Clinica
Executive Summary
The US FDA remains unconvinced that silicone gel-filled breast implants are safe. Although there is no hard evidence that the products cause autoimmune diseases or rheumatologic disorders, the agency is strictly limiting use of the implants. They may be given only as part of clinical trials, for reconstructive surgery and a few augmentative procedures. Last Tuesday, Congress wanted to know why. Clinica's Washington correspondent, Duffy Miller, reports from the August 1st House hearings on Capitol Hill.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.